Commemorate World Parkinson’s Day With ACS Chemical Neuroscience

The European Parkinson’s Disease Association and Parkinson’s UK recognize April 11, 2018, as World Parkinson’s Day. Millions of people worldwide are affected by this condition and this campaign seeks to raise awareness and understanding of Parkinson’s Disease using the hashtag#UniteForParkinsons. The disease is named for James Parkinson, most famous for publishing ‘An Essay on the Shaking Palsy’ in 1817. In support of this day, and to continue to promote scientific publication that furthers the research and development of new treatments for this neurological disorder, ACS Chemical Neuroscience is pleased to feature the below research on this subject.

Mechanism Underlying the Effectiveness of Deferiprone in Alleviating Parkinson’s Disease Symptoms
ACS Chem. Neurosci., Article ASAP
DOI: 10.1021/acschemneuro.7b00478

Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an Update
ACS Chem. Neurosci., 2017, 8 (5), pp 973–986
DOI: 10.1021/acschemneuro.6b00440

The Medicinal Chemistry of Natural and Semisynthetic Compounds against Parkinson’s and Huntington’s Diseases
ACS Chem. Neurosci., 2017, 8 (11), pp 2356–2368
DOI: 10.1021/acschemneuro.7b00283

Gene Expression-Based Screen for Parkinson’s Disease Identifies GW8510 as a Neuroprotective Agent
ACS Chem. Neurosci., 2016, 7 (7), pp 857–863
DOI: 10.1021/acschemneuro.6b00076

Synthesis, Structure Characterization, and Evaluation in Microglia Cultures of Neuromelanin Analogues Suitable for Modeling Parkinson’s Disease
ACS Chem. Neurosci., 2017, 8 (3), pp 501–512
DOI: 10.1021/acschemneuro.6b00231

Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson’s Disease: Correlation between Plasma and Cerebrospinal Fluid Levels
ACS Chem. Neurosci., 2017, 8 (6), pp 1170–1176
DOI: 10.1021/acschemneuro.7b00063

An 11-mer Amyloid Beta Peptide Fragment Provokes Chemical Mutations and Parkinsonian Biomarker Aggregation in Dopaminergic Cells: A Novel Road Map for “Transfected” Parkinson’s
ACS Chem. Neurosci., 2016, 7 (11), pp 1519–1530
DOI: 10.1021/acschemneuro.6b00159

Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson’s Disease
ACS Chem. Neurosci., 2017, 8 (7), pp 1519–1529
DOI: 10.1021/acschemneuro.7b00050

Identification of a Novel 1,4,8-Triazaphenanthrene Derivative as a Neuroprotectant for Dopamine Neurons Vulnerable in Parkinson’s Disease
ACS Chem. Neurosci., 2017, 8 (6), pp 1222–1231
DOI: 10.1021/acschemneuro.6b00385

A Novel Iron(II) Preferring Dopamine Agonist Chelator as Potential Symptomatic and Neuroprotective Therapeutic Agent for Parkinson’s Disease
ACS Chem. Neurosci., 2017, 8 (4), pp 723–730
DOI: 10.1021/acschemneuro.6b00356

Get stories like this one in your inbox every month. Sign up for a custom newsletter from ACS Axial.

If you have comments or questions for the author of this post, please e-mail: Axial@acs.org.